A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

Califf RM, Adams KF, McKenna WJ, Gheorghiade M, Uretsky BF, McNulty SE, Darius H, Schulman K, Zannad F, Handberg-Thurmond E, Harrell FE, Wheeler W, Soler-Soler J, Swedberg K
Am Heart J. 1997 134 (1): 44-54

PMID: 9266782 · DOI:10.1016/s0002-8703(97)70105-4

MeSH Terms (26)

Aged Angiography Angiotensin-Converting Enzyme Inhibitors Antihypertensive Agents Cardiac Output Cardiotonic Agents Cause of Death Digoxin Diuretics Epoprostenol Exercise Tolerance Female Heart Failure Humans Infusions, Intravenous Male Middle Aged Proportional Hazards Models Pulmonary Wedge Pressure Quality of Life Risk Factors Stroke Volume Survival Rate Vascular Resistance Ventricular Dysfunction, Left Walking

Connections (1)

This publication is referenced by other Labnodes entities:

Links